News from NYU Langone Health
NYU Langone—Suffolk opens pantry to address food insecurity
Long Island Business News
NYU Langone Hospital—Suffolk has opened a food pantry in its main lobby to address food insecurity for patients upon their discharge. Located in Patchogue, the pantry provides nutritious food to promote healthier recovery and address social determinants of health. According to Kathryn Lang, DNP, RN, NE-BC, vice president of nursing and patient care services at NYU Langone Hospital—Suffolk, the initiative is driven by staff passion for patient care. Michael DeCicco, director of patient experience and culture, added that it demonstrates a commitment to whole-person care. The program was developed in partnership with Island Harvest.
9/16/2026
NYU Langone study find GLP-1 use expedites hair loss
Spectrum News NY1
A new study from NYU Langone Health has identified a link between the use of GLP-1 weight loss drugs and hair loss in some men. The research found that men who are already genetically predisposed to hair loss may increase their risk by 7% when using these medications. Lynn Petukhova, PhD, assistant professor in Ronald O. Perelman Department of Dermatology and Department of Population Health at NYU Grossman School of Medicine, joined NY1 to discuss the findings.
Also reporting was: SciTechDaily
9/16/2026
Improving the transition from pediatric to adult epilepsy care
NeurologyLive
Jacqueline French, MD, professor of neurology at NYU Grossman School of Medicine and co-director of epilepsy research and epilepsy clinical trials at NYU Langone Health, examines challenges in the transition from pediatric to adult epilepsy care. She discusses how pediatric teams possess years of specific knowledge about patients with complex conditions, a level of detail that is difficult to transfer to adult care providers. Dr. French notes that pediatric care models are often more holistic. To improve these transitions, she suggests direct clinician-to-clinician communication and the implementation of an 'epilepsy passport' to maintain a comprehensive record of a patient's medical journey.
9/16/2026
The expanding role of genetic testing in epilepsy
NeurologyLive
Jacqueline French, MD, professor of neurology at NYU Grossman School of Medicine and co-director of epilepsy research and epilepsy clinical trials at NYU Langone Health, discusses the expanding role of genetic testing in epilepsy. She explains that testing has its greatest diagnostic yield among children with seizures and developmental delays. According to French, a genetic diagnosis provides prognostic information, guides screening for associated comorbidities, and connects families with disease-specific communities. The discussion also covers challenges of genetic testing in adults and interpreting variants of uncertain significance.
9/16/2026
Simple workflow fixes can close CKM care gaps, clinicians say
American Journal of Managed Care
Simple operational changes are more effective than education alone in closing care gaps for cardiovascular-kidney-metabolic syndrome, according to clinicians at recent roundtables. At a New York event, Olugbenga Ogedegbe, MD, MPH, director of the Institute for Excellence in Health Equity at NYU Langone Health, discussed “task-shifting” duties to improve efficiency. Shaline Rao, MD, chief of the Division of Cardiology at NYU Langone Hospital–Long Island, highlighted the challenge of assigning ownership for patients seeing multiple specialists. Amrita Mukhopadhyay, MD, the Eugene Braunwald, MD Assistant Professor of Cardiology at NYU Grossman School of Medicine, cited long wait times as a bottleneck. David Charytan, MD, director of the Division of Nephrology at NYU Langone Health, also supported task-shifting.
9/16/2026
Parade Magazine
Neurologists recommend pomegranates for midlife brain health due to their high levels of specialized polyphenols, which offer significant anti-inflammatory and antioxidant qualities. These compounds help protect aging brain tissue from daily degradation and may lower the risk of conditions like Alzheimer's. The article also cites Shae Datta, MD, a neurologist at NYU Langone Hospital–Long Island and co-director of the NYU Langone Concussion Center, who previously explained that flavonoids in dark berries can cross the blood-brain barrier to reduce inflammation and boost mental speed. A variety of colorful produce is recommended for comprehensive brain care.
Also reporting was: Wichita Eagle, Centre Daily Times, Columbus Ledger-Enquirer, Yahoo Health, The Sun News, The Telegraph (Macon), The State, Merced Sun-Star, Miami Herald, Tacoma News Tribune, Bradenton Herald, Tri-City Herald, The Island Packet
9/16/2026
Less frequent colonoscopy after polyp removal could be the way to go, study suggests
MedPage Today
An interim analysis from an ongoing trial suggests surveillance colonoscopy 5 years after removing high-risk adenomas is noninferior to a 3-year interval for detecting colorectal cancer. Published in the New England Journal of Medicine, the study found cumulative cancer incidence was 0.77% in the 5-year group versus 0.82% in the 3-year group. In an accompanying editorial, Aasma Shaukat, MD, MPH, the Robert M. and Mary H. Glickman Professor of Medicine and director of outcomes research in the division of gastroenterology and hepatology at NYU Grossman School of Medicine, noted the trial provides an 'important corrective' and that surveillance policy must be determined by evidence.
Also reporting was: MSN
9/16/2026
Intravascular imaging consistently improves PCI outcomes, new meta-analysis confirms
Cardiovascular Business
A new meta-analysis in JACC finds that percutaneous coronary intervention (PCI) guided by intravascular imaging is associated with a significantly lower risk of adverse cardiovascular events than angiography-guided procedures. The research, which analyzed 28 trials with over 24,000 patients, showed consistent reductions in target lesion failure, myocardial infarction, and mortality. First author Sripal Bangalore, MD, an interventional cardiologist and professor of medicine at NYU Langone Health, and colleagues wrote that the evidence supports making intravascular imaging-guided intervention a routine part of state-of-the-art PCI for complex coronary artery disease.
9/16/2026
How can you tell if a guy is depressed? Here's the 1 key thing therapists always look for.
Men's Health
Depression in men often presents as externalizing behaviors like anger, increased irritability, or escapism rather than sadness. According to Dan Iosifescu, MD, psychiatrist at NYU Langone Health, men are often trained to believe they should be strong and that depression is not part of their experience. This stigma, along with diagnostic tools that emphasize sadness, contributes to men being diagnosed at half the rate of women. The article notes that screening tools often miss male-presenting symptoms. It concludes with advice for approaching loved ones, suggesting direct, non-confrontational observations to open a dialogue.
9/16/2026
Your neighborhood could influence your dementia risk
National Geographic
A Cambridge University study found that dementia-related deaths in England from 2011 to 2023 were highest in suburbs and mid-density neighborhoods, not cities or rural areas. The research highlights how environmental factors influence brain health. Commenting on the findings, Jordan Weiss, PhD, assistant professor at the Optimal Aging Institute at NYU Grossman School of Medicine, stated that a neighborhood 'sets the dose' on established dementia risk factors. Weiss also noted that untreated hearing loss can strain the brain and recommended getting hearing tested as a key preventative action.
9/16/2026
Rented e-scooters, e-bikes increasingly threaten blind Portlanders as safeguards fail
Street Roots
A report on the hazards that rented e-scooters and e-bikes pose to blind residents in Portland, Oregon, highlights failures in safety measures by rental companies. The article references a 2026 study from NYU Langone Health which found emergency room visits in New York City related to these devices surged from under 10% in 2018 to over 50% by 2023. According to the study, one-third of those patients suffered traumatic brain injuries, with pedestrians being injured at nearly double the rate of riders, underscoring the broader safety risks of the devices.
9/16/2026
Infection risk as a driver of frontline treatment selection in chronic lymphocytic leukemia
OncLive
In a discussion, Marc Braunstein, MD, PhD, associate professor of medicine at NYU Grossman Long Island School of Medicine, and Danielle M. Brander, MD, of Duke University School of Medicine, examined infection as a leading risk in chronic lymphocytic leukemia (CLL). They noted that registry data indicates nearly half of patients develop a serious infection, which contributes to almost one-third of deaths. Dr. Braunstein favors continuous therapy for specific disease types and advises counseling patients that infection is the key risk associated with chemotherapy-free regimens, based on infection rate data from multiple clinical trials.
9/16/2026
FDA clears AI platform for PET imaging enhancement and quantification
Radiology Business
The FDA has granted 510(k) clearance to Microstructure Imaging for its MICSI-PET software platform, which uses structural MRI to enhance neurological PET images. Microstructure Imaging is an NYU Langone Health spinoff. The company is also pursuing further clinical validation for an upcoming neuroimaging platform with a $2.275 million National Cancer Institute award, which will support a multicenter study conducted in collaboration with NYU Langone Health and Memorial Sloan Kettering Cancer Center. The technology aims to improve visualization for evaluating neurodegenerative diseases like Alzheimer's.
Also reporting was: Aunt Minnie
9/16/2026
She lived with headaches and brain fog for years. Then she tried magic mushrooms.
The Washington Post
Research into psilocybin as a potential treatment for various conditions, including anxiety, depression, and PTSD, is expanding with over 300 human studies underway. As the Food and Drug Administration considers the therapeutic use of psychedelic drugs, experts are raising concerns about implementation. Petros Petridis, MD, a psychiatrist and researcher at NYU Langone's Center for Psychedelic Medicine, worries that demand could outstrip the number of clinicians trained to provide these therapies properly. He states psychedelic therapy should be treated like a complex medical procedure, requiring extensive screening and supervision, rather than a simple prescription to avoid harming patients.
9/17/2026
Scientists grew more human brain tissue in a mouse than ever before—and people have questions
Gizmodo
Researchers at Stanford University have developed a new technique to grow human brain organoids in mice, which take up more space and mimic complex brain functions. This advancement aims to improve the study of neurological disorders but also raises ethical questions. Commenting on the findings, Arthur Caplan, PhD, a bioethicist and professor emeritus at NYU Grossman School of Medicine, noted that while the model is valuable, predictions about its immediate impact on understanding human diseases may be overly optimistic. He also called for more transparent public debate on such research.
Also reporting was: Aol
9/16/2026
